Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer
Comment: Adjuvant ipilimumab in high-risk melanoma
Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma
Comment: Immunotherapy combo increases median survival in advanced melanoma
Success for ipilimumab and nivolumab combo in advanced melanoma
Comment: CALGB/SWOG 80405 study on chemo combos in colorectal
Discontinuing statins near the end of life is safe, improves patient quality of life
Impact of cytotoxics on pregnancy needs to be better understood
T-VEC injections into melanoma lesions show significant response rate
Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer
Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence
ASCO 2014 roundup